SmileDirectClub and its rivals offer less-expensive dental work without visiting a doctor’s office. Is it safe?
The future of health, and the business of getting there
The Future of Medicine
Data & Disruption
Spread pricing, where pharmacy benefit managers like CVS mark up—sometimes dramatically—the difference between the amount they reimburse pharmacies for a drug and the amount they charge their clients.
The Business of Drugs
Patients, Profits & Policy
Investors Chase Cannabis Highs After Crypto Crash
Cannabis stock Tilray Inc. racked up high volume this week as pot becomes the latest asset to seize on the fascination of investors. Bloomberg's Romaine Bostick, Luke Kawa, and Joe Weisenthal examine the market moves on "Bloomberg Markets: The Open." (Source: Bloomberg)
CVS CEO Says Merger With Aetna Is in 'Home Stretch'
Thiel-Backed Fund Scores Big With $12 Billion Tilray Stake
Tilray Shares Soar as CEO Touts Growth Potential
Coca-Cola Would Be a Great Partner, Aurora Cannabis CEO Says
In Case You Missed It
Bloomberg's index looks at whether Trump's rhetoric on prices has had a major impact.
The Singh brothers were heirs to a health-care empire.
An anomaly in the way some people process fructose could help find new drugs for diseases linked to weight.
Virtually all of the company’s revenue comes from animal slaughter and processing. Now its new CEO is pouring money into animal-free alternatives.